Literature DB >> 10614719

Antioxidants attenuate nuclear factor-kappa B activation and tumor necrosis factor-alpha production in alcoholic hepatitis patient monocytes and rat Kupffer cells, in vitro.

D B Hill1, R Devalaraja, S Joshi-Barve, S Barve, C J McClain.   

Abstract

UNLABELLED: There is increased tumor necrosis factor-alpha (TNF) activity in alcoholic hepatitis (AH).
OBJECTIVES: To examine the effects of antioxidants and glutathione enhancing agents on NF-kappaB activation and TNF production in Kupffer cells and monocytes. DESIGN AND METHODS: Isolated rat Kupffer cells and peripheral blood monocytes from AH patients were treated in vitro. NF-kappaB activation was assessed by electrophoretic mobility shift assay and TNF was measured in cell culture supernatants.
RESULTS: Monocytes from AH patients had greater TNF production compared to normal volunteers. Pretreatment with antioxidants or gluathione enhancing agents inhibited TNF production and NF-kappaB activation in both monocytes from normal and AH patients as well as in rat Kupffer cells.
CONCLUSIONS: There may be a therapeutic role for antioxidants or glutathione enhancing agents in disease states with increased TNF activity such as AH.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10614719     DOI: 10.1016/s0009-9120(99)00056-9

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  17 in total

Review 1.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

Review 2.  Pathophysiological basis for antioxidant therapy in chronic liver disease.

Authors:  Jesús Medina; Ricardo Moreno-Otero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis.

Authors:  Thuy-Anh Le; Rohit Loomba
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

Review 4.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

Review 5.  Treatment of alcoholic liver disease.

Authors:  Ina Bergheim; Craig J McClain; Gavin E Arteel
Journal:  Dig Dis       Date:  2005       Impact factor: 2.404

6.  Treatment of alcoholic liver disease.

Authors:  Thomas H Frazier; Abigail M Stocker; Nicole A Kershner; Luis S Marsano; Craig J McClain
Journal:  Therap Adv Gastroenterol       Date:  2011-01       Impact factor: 4.409

7.  Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice.

Authors:  Megan R McMullen; Michele T Pritchard; Qifang Wang; Carrie A Millward; Colleen M Croniger; Laura E Nagy
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

8.  Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B.

Authors:  Mukund Ramchandra Mogarekar; Swati Jitendra Talekar
Journal:  Indian J Gastroenterol       Date:  2013-05-23

Review 9.  Signaling mechanisms in alcoholic liver injury: role of transcription factors, kinases and heat shock proteins.

Authors:  Pranoti Mandrekar
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

10.  Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production.

Authors:  Varsha Thakur; Michele T Pritchard; Megan R McMullen; Qifang Wang; Laura E Nagy
Journal:  J Leukoc Biol       Date:  2006-03-22       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.